Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01986049

Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain

Phase 3 Study Comparing Transversus Abdominis Plane Block After Caesarian Section Usin Bupivacaine 0.5% vs. Bupivacaine 0.25% vs. Placebo (Normal Saline).

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
New York Presbyterian Brooklyn Methodist Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Adding TAP block with Bupivacaine may decrease the use of PCA bolus use after caesarean section for pain relief.

Detailed description

Participants in the study will be randomized to TAP block with 0.5% or 0.25% bupivacaine or with placebo (normal saline). The number of PCA bolus used within 24 hours post cesarean section will be compared between the groups.

Conditions

Interventions

TypeNameDescription
DRUGBupivicaine

Timeline

Start date
2013-02-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2013-11-18
Last updated
2021-10-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01986049. Inclusion in this directory is not an endorsement.